166 related articles for article (PubMed ID: 18419630)
21. The epidemiology of Candida colonization and invasive candidiasis in a surgical intensive care unit where fluconazole prophylaxis is utilized: follow-up to a randomized clinical trial.
Magill SS; Swoboda SM; Shields CE; Colantuoni EA; Fothergill AW; Merz WG; Lipsett PA; Hendrix CW
Ann Surg; 2009 Apr; 249(4):657-65. PubMed ID: 19300221
[TBL] [Abstract][Full Text] [Related]
22. Therapeutic experience with fluconazole in the treatment of fungal infections in diabetic patients.
Penk A; Pittrow L
Mycoses; 1999; 42 Suppl 2():97-100. PubMed ID: 10865913
[TBL] [Abstract][Full Text] [Related]
23. Does zinc sulfate prevent therapy-induced taste alterations in head and neck cancer patients? Results of phase III double-blind, placebo-controlled trial from the North Central Cancer Treatment Group (N01C4).
Halyard MY; Jatoi A; Sloan JA; Bearden JD; Vora SA; Atherton PJ; Perez EA; Soori G; Zalduendo AC; Zhu A; Stella PJ; Loprinzi CL
Int J Radiat Oncol Biol Phys; 2007 Apr; 67(5):1318-22. PubMed ID: 17394940
[TBL] [Abstract][Full Text] [Related]
24. A comparative study of the efficacy of fluconazole and amphotericin B in the treatment of oropharyngeal candidosis in patients undergoing radiotherapy for head and neck tumours.
Finlay PM; Richardson MD; Robertson AG
Br J Oral Maxillofac Surg; 1996 Feb; 34(1):23-5. PubMed ID: 8645677
[TBL] [Abstract][Full Text] [Related]
25. Therapeutic effect of recombinant human epidermal growth factor (RhEGF) on mucositis in patients undergoing radiotherapy, with or without chemotherapy, for head and neck cancer: a double-blind placebo-controlled prospective phase 2 multi-institutional clinical trial.
Wu HG; Song SY; Kim YS; Oh YT; Lee CG; Keum KC; Ahn YC; Lee SW
Cancer; 2009 Aug; 115(16):3699-708. PubMed ID: 19514089
[TBL] [Abstract][Full Text] [Related]
26. Prophylaxis of candidiasis in cancer patients.
Bodey GP; Samonis G; Rolston K
Semin Oncol; 1990 Jun; 17(3 Suppl 6):24-8. PubMed ID: 2191444
[TBL] [Abstract][Full Text] [Related]
27. Efficacy, tolerability and development of resistance in HIV-positive patients treated with fluconazole for secondary prevention of oropharyngeal candidiasis: a randomized, double-blind, placebo-controlled trial.
Pagani JL; Chave JP; Casjka C; Glauser MP; Bille J
J Antimicrob Chemother; 2002 Aug; 50(2):231-40. PubMed ID: 12161404
[TBL] [Abstract][Full Text] [Related]
28. Phase II study of palifermin and concurrent chemoradiation in head and neck squamous cell carcinoma.
Brizel DM; Murphy BA; Rosenthal DI; Pandya KJ; Glück S; Brizel HE; Meredith RF; Berger D; Chen MG; Mendenhall W
J Clin Oncol; 2008 May; 26(15):2489-96. PubMed ID: 18487568
[TBL] [Abstract][Full Text] [Related]
29. Candida glabrata oropharyngeal candidiasis in patients receiving radiation treatment for head and neck cancer.
Redding SW; Kirkpatrick WR; Coco BJ; Sadkowski L; Fothergill AW; Rinaldi MG; Eng TY; Patterson TF
J Clin Microbiol; 2002 May; 40(5):1879-81. PubMed ID: 11980984
[TBL] [Abstract][Full Text] [Related]
30. Fluconazole prophylaxis in patients with head and neck tumours undergoing radiation and radiochemotherapy.
Mücke R; Kaben U; Libera T; Knauerhase H; Ziegler PG; Hamann D; Strietzel M
Mycoses; 1998 Nov; 41(9-10):421-3. PubMed ID: 9916467
[TBL] [Abstract][Full Text] [Related]
31. Safety and efficacy of the specific endothelin-A receptor antagonist ZD4054 in patients with hormone-resistant prostate cancer and bone metastases who were pain free or mildly symptomatic: a double-blind, placebo-controlled, randomised, phase 2 trial.
James ND; Caty A; Borre M; Zonnenberg BA; Beuzeboc P; Morris T; Phung D; Dawson NA
Eur Urol; 2009 May; 55(5):1112-23. PubMed ID: 19042080
[TBL] [Abstract][Full Text] [Related]
32. Cost-effectiveness analysis of micafungin versus fluconazole for prophylaxis of invasive fungal infections in patients undergoing hematopoietic stem cell transplantation in Korea.
Sohn HS; Lee TJ; Kim J; Kim D
Clin Ther; 2009 May; 31(5):1105-15; discussion 1066-8. PubMed ID: 19539111
[TBL] [Abstract][Full Text] [Related]
33. A prospective, randomized, double-blind, placebo-controlled trial evaluating the effect of nystatin on the development of oral irritation in patients receiving high-dose intravenous interleukin-2.
Ohnmacht GA; Phan GQ; Mavroukakis SA; Steinberg SM; Shea YR; Witebsky FG; McIntyre LS; Goodwin RS; Muehlbauer PM; Morton KE; Rogers-Freezer LJ; Seipp CA; Rosenberg SA; Marincola FM
J Immunother; 2001; 24(2):188-92. PubMed ID: 11265777
[TBL] [Abstract][Full Text] [Related]
34. [Use of fluconazole as antimycotic prophylaxis in radiotherapy of patients with head and neck tumors].
Mücke R; Kaben U; Libera T; Knauerhase H; Ziegler PG; Hamann D; Strietzel M
Mycoses; 1997; 40 Suppl 1():53-5. PubMed ID: 9417514
[TBL] [Abstract][Full Text] [Related]
35. Prophylactic fluconazole in liver transplant recipients: a randomized, double-blind, placebo-controlled trial.
Patel R
Liver Transpl; 2000 May; 6(3):376-9. PubMed ID: 10827245
[No Abstract] [Full Text] [Related]
36. Candida glabrata is an emerging cause of oropharyngeal candidiasis in patients receiving radiation for head and neck cancer.
Redding SW; Dahiya MC; Kirkpatrick WR; Coco BJ; Patterson TF; Fothergill AW; Rinaldi MG; Thomas CR
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2004 Jan; 97(1):47-52. PubMed ID: 14716255
[TBL] [Abstract][Full Text] [Related]
37. Value of antifungal prophylaxis with antifungal drugs against oropharyngeal candidiasis in cancer patients.
Meunier F; Paesmans M; Autier P
Eur J Cancer B Oral Oncol; 1994 May; 30B(3):196-9. PubMed ID: 7920166
[TBL] [Abstract][Full Text] [Related]
38. Fluconazole once a week as secondary prophylaxis against oropharyngeal candidiasis in HIV-infected patients. A double-blind placebo-controlled study.
Marriott DJ; Jones PD; Hoy JF; Speed BR; Harkness JL
Med J Aust; 1993 Mar; 158(5):312-6. PubMed ID: 8097273
[TBL] [Abstract][Full Text] [Related]
39. Fluconazole for oropharyngeal candidiasis in anti-HIV positive haemophiliacs.
Lim SG; Lee CA; Hales M; O'Doherty M; Winter M; Kernoff PB
Aliment Pharmacol Ther; 1991 Apr; 5(2):199-205. PubMed ID: 1888820
[TBL] [Abstract][Full Text] [Related]
40. Efficacy of roxithromycin in adult patients with rheumatoid arthritis who had not received disease-modifying antirheumatic drugs: a 3-month, randomized, double-blind, placebo-controlled trial.
Ogrendik M
Clin Ther; 2009 Aug; 31(8):1754-64. PubMed ID: 19808134
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
